Search
Our Ser­vices / In­form / E-alert Archive / On­line Event Im­pact on Can­cer

Online Event Impact on Cancer

How IHI and IMI projects are tackling cancer. On 19 May from 10:30 am to 12 noon the Innovative Health Initiative is organising an online event highlighting their projects impact on Cancer.
Although Europe accounts for only one tenth of the world’s population, a quarter of all cancer cases are found  in Europe. So far, IMI and IHI have funded 22 cancer projects with public and private investments addressing various aspects of the prevention, diagnosis and treatment of cancer.

All the speakers are from these IMI or IHI projects:

  • PIONEER used big data to address key knowledge gaps related to the screening, diagnosis and treatment of prostate cancer patients.
  • OPTIMA is harnessing the power of AI to advance treatments and facilitate decision-making for physicians and patients with prostate, breast and lung cancer.
  • CANCER-ID advanced the science that will lead to more widespread use of liquid biopsy (a blood test that detects signs of cancerous tumors, including tumor cells and cancer cell DNA in the blood) in clinical trials of cancer drugs, and in the clinical treatment of patients with cancer.
  • GUIDE-MRD is exploring how blood tests could be used to identify which patients might benefit from additional treatment, and which patients would likely not benefit from treatment. 
  • IMAGIO, a new IHI project that focuses on ‘interventional oncology’, which uses miniaturised instruments to target cancer cells more precisely, thereby sparing health cells.

The speakers during this event will be sharing their project experiences and expertise:

  • James N’dow, Professor of Urological Surgery, University of Aberdeen (PIONEER & OPTIMA)
  • Robert Hofsink, Manager of Public Private Partnerships at Philips Image Guided Therapy (IMAGIO)
  • Klaus Pantel, Director and Professor of Medicine at the University Medical Center Hamburg-Eppendorf (GUIDE.MRD & CANCER-ID)
  • Susan Evans Axelsson, Medical Advisor and General Manager of the European Association of Urology UroEvidence Hub and Bayers AG (PIONEER)
  • Coosje Verhagen, PhD candidate at Leiden University Medical Center (IMAGIO)

Find out more and register here.